Ubs Group Ag Zimmer Biomet Holdings, Inc. Put Options Transaction History

Ubs Group Ag

10 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$104.47 - $116.17 $313,410 - $348,510	-3,000 Reduced 19.11%	12,700 $1.37 Million
Q2 2024 Aug 13, 2024	SELL	$106.25 - $130.01 $488,750 - $598,046	-4,600 Reduced 22.66%	15,700 $1.7 Million
Q1 2024 May 13, 2024	BUY	$119.98 - $132.61 $2.44 Million - $2.69 Million	20,300 New	20,300 $2.68 Million
Q4 2020 Feb 11, 2021	SELL	$128.25 - $151.41 $820,800 - $969,024	-6,400 Reduced 42.67%	8,600 $1.33 Million
Q2 2020 Jul 31, 2020	BUY	$87.02 - $133.4 $678,756 - $1.04 Million	7,800 Added 108.33%	15,000 $1.79 Million
Q4 2019 Feb 14, 2020	BUY	$127.4 - $146.83 $573,300 - $660,735	4,500 Added 166.67%	7,200 $1.08 Million
Q2 2019 Aug 14, 2019	SELL	$108.87 - $125.09 $2.42 Million - $2.78 Million	-22,200 Reduced 89.16%	2,700 $318,000
Q1 2019 May 14, 2019	BUY	$97.5 - $125.79 $2.21 Million - $2.86 Million	22,700 Added 1031.82%	24,900 $3.18 Million
Q4 2017 Feb 14, 2018	SELL	$105.55 - $120.83 $8.61 Million - $9.86 Million	-81,600 Reduced 97.37%	2,200 $265,000
Q2 2017 Aug 14, 2017	BUY	N/A	83,800	83,800 $10.8 Million

1,079

178M

301K

Ticker ZBH
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 209,820,000
Market Cap $22.5B
Description
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, bi...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.